Atomo Diagnostics 2020 Investor Update

Atomo Diagnostics Limited is an Australian medical device company specializing in integrated rapid diagnostic test (RDT) devices for infectious diseases, including COVID-19 and HIV. The company's patented devices simplify testing procedures and have regulatory approvals in Australia, EU, and UK, with WHO prequalification for its HIV self-test. As of April 2020, Atomo had sold over 1.2 million rapid test devices globally through healthcare distributors and OEM agreements.